Back to series
#ESC2021 Hotline: Results from the FIGARO-DKD trial Effect of finerenone on cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes
MedShr Editor

#ESC2021 Hotline: Results from the FIGARO-DKD trial Effect of finerenone on cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes

MedShr Editor
Expected completion time: 15 mins
0.25 CPD Credit

#ESC2021 Hotline Presentation

Sign up to start learning
,